At1g11450 Antibody

What is At1g11450 and why are antibodies against this protein important for Arabidopsis research?

At1g11450 is an Arabidopsis thaliana gene locus encoding a protein involved in plant cellular processes. Antibodies targeting this protein are crucial for investigating its expression patterns, subcellular localization, and functional roles in plant development. Understanding At1g11450 protein localization at subcellular, cellular, and tissue levels contributes to better comprehension of its function in cell dynamics, protein-protein interactions, and regulatory networks . Similar to other plant protein studies, these antibodies enable researchers to conduct immunoblotting, immunoprecipitation, and immunocytochemistry experiments to characterize protein behavior under various conditions.

What approaches are used to generate antibodies against Arabidopsis proteins like At1g11450?

Two primary approaches are used to generate antibodies against Arabidopsis proteins:

• Peptide-based antibodies: Generated using small synthetic peptides corresponding to unique regions of the target protein. This approach often has lower success rates for plant proteins .

• Recombinant protein-based antibodies: Produced using purified recombinant protein expressed in heterologous systems. This approach typically yields higher success rates for plant proteins .

For optimal results, affinity purification of antibodies significantly improves detection rates. In documented cases, affinity purification has increased the high-confidence detection rate to 55% for Arabidopsis protein antibodies .

How should I validate the specificity of an At1g11450 antibody before experimental use?

Thorough validation of At1g11450 antibody specificity requires multiple complementary approaches:

• Western blot analysis using wild-type and knockout mutants: Compare protein expression between wild-type Arabidopsis and At1g11450 knockout lines. A specific antibody will detect a band of the expected molecular weight in wild-type samples that is absent in the knockout mutant, similar to validation performed for other Arabidopsis proteins .

• Protein overexpression verification: Analyze protein extracts from plants overexpressing At1g11450 (native or tagged versions) to confirm increased signal intensity at the expected molecular weight .

• Peptide competition assay: Pre-incubate the antibody with the immunizing peptide before immunodetection. Specific antibodies will show significantly reduced signal when blocked with the cognate peptide.

• Cross-reactivity testing: Test the antibody against related Arabidopsis proteins to ensure it doesn't cross-react with homologous proteins.

What are the optimal fixation and sample preparation methods for At1g11450 immunolocalization studies?

Based on protocols established for other Arabidopsis proteins, the following methods are recommended:

For whole-mount immunolocalization in Arabidopsis tissues:

• Fixation: Use 4% paraformaldehyde in PBS (pH 7.4) for 60-90 minutes at room temperature under vacuum.

• Permeabilization: Treat samples with 0.1-0.5% Triton X-100 for 15-30 minutes to allow antibody penetration into plant tissues.

• Cell wall digestion: For improved antibody penetration, include a partial cell wall digestion step using a mixture of cellulase (1%) and macerozyme (0.2-0.5%) for 10-15 minutes.

• Blocking: Use 3-5% BSA or normal serum in PBS for 60 minutes to reduce non-specific binding.

• Antibody incubation: Dilute primary antibodies (1:100 to 1:500) in blocking solution and incubate overnight at 4°C followed by appropriate secondary antibody incubation.

These methods can be adjusted based on protein abundance and subcellular location, similar to approaches used for other cytosolic proteins like ACBP6 .

What strategies can address weak or absent signals when using At1g11450 antibodies in western blots?

When experiencing weak or absent signals, consider these methodological adjustments:

For optimal results with plant protein antibodies, affinity purification has been shown to dramatically improve detection rates, as demonstrated in studies with other Arabidopsis antibodies .

How can I optimize chromatin immunoprecipitation (ChIP) protocols for At1g11450 antibodies?

Based on successful ChIP-seq studies with Arabidopsis proteins, the following optimizations are recommended:

• Crosslinking: Optimize formaldehyde concentration (1-2%) and fixation time (10-15 minutes) to effectively capture protein-DNA interactions without overfixation.

• Sonication conditions: Adjust sonication parameters to obtain DNA fragments between 200-500 bp for optimal immunoprecipitation and sequencing.

• Antibody selection: Use affinity-purified antibodies when possible, as this significantly improves specificity. Alternatively, using epitope-tagged versions (like GFP-tagged At1g11450) with well-characterized anti-tag antibodies (e.g., anti-GFP) can be highly effective .

• Negative controls: Include proper controls such as:

  • Input chromatin (pre-immunoprecipitation)

  • ChIP with IgG from the same species as the primary antibody

  • ChIP from knockout/knockdown lines

• Validation: Verify enrichment of known or predicted target regions by qPCR before proceeding to sequencing, similar to methods used for LEC1 binding site identification .

How do I interpret conflicting subcellular localization data between At1g11450 antibody immunostaining and fluorescent protein fusion studies?

When faced with discrepancies between antibody-based localization and fluorescent protein fusion results:

• Validate both approaches independently:

  • For antibody detection: Test specificity in western blots comparing wild-type and knockout lines

  • For fusion proteins: Verify functionality through complementation of knockout phenotypes

• Consider technical factors:

  • Antibody accessibility: Some subcellular compartments may be less accessible to antibodies

  • Tag interference: Fluorescent protein tags may disrupt localization signals or protein folding

  • Fixation artifacts: Different fixation methods can alter protein localization patterns

• Perform subcellular fractionation: Isolate cellular components (cytosolic, membrane, nuclear fractions) and analyze protein distribution by western blotting with the antibody. This approach can provide biochemical evidence for localization, similar to methods used for ACBP6 localization studies .

• Use multiple detection methods: Combine immunogold electron microscopy, confocal microscopy of fluorescent protein fusions, and biochemical fractionation to build a comprehensive picture of protein localization.

When interpreting conflicting data, consider that proteins may have multiple subcellular locations or that localization may change under different conditions or developmental stages.

What considerations are important when analyzing protein abundance changes of At1g11450 under stress conditions?

When analyzing At1g11450 protein abundance changes under stress conditions:

• Establish proper experimental timeline: Monitor protein levels at multiple time points (e.g., 0, 6, 12, 24, and 48 hours) after stress induction, as protein changes may not be immediate. Studies of stress-responsive Arabidopsis proteins like ACBP6 showed maximum accumulation at 48h after cold treatment .

• Compare protein with transcript levels: Perform parallel northern blot or RT-qPCR analyses to determine whether protein abundance changes correlate with transcript levels, which can reveal post-transcriptional regulation mechanisms .

• Include appropriate controls:

  • Untreated samples at each time point (to control for developmental or circadian effects)

  • Loading controls (constitutively expressed proteins not affected by the stress)

  • Positive controls (proteins known to respond to the specific stress)

• Quantify western blot results: Use densitometry to quantify protein band intensity, normalizing to loading controls. Present data as fold change relative to untreated samples.

• Statistical analysis: Perform experiments with at least three biological replicates and apply appropriate statistical tests to determine the significance of observed changes.

How can I use At1g11450 antibodies to investigate protein-protein interactions in planta?

To investigate At1g11450 protein-protein interactions in planta, consider these methodological approaches:

• Co-immunoprecipitation (Co-IP):

  • Use At1g11450 antibody to immunoprecipitate the protein complex from plant extracts

  • Analyze co-precipitated proteins by mass spectrometry or western blotting with antibodies against suspected interacting partners

  • Include appropriate negative controls (IgG, knockout lines) to identify non-specific interactions

• Proximity-dependent labeling:

  • Express At1g11450 fused to a proximity labeling enzyme (BioID or TurboID)

  • Use the At1g11450 antibody to verify expression and localization of the fusion protein

  • Identify biotinylated proteins as potential interaction partners

• Bimolecular Fluorescence Complementation (BiFC) validation:

  • Identify potential interaction partners from Co-IP or proximity labeling results

  • Confirm interactions using BiFC in Arabidopsis protoplasts or stable transgenic lines

  • Use the At1g11450 antibody to verify expression levels of native protein alongside the fusion constructs

• Antibody-based FRET:

  • Use labeled primary or secondary antibodies directed against At1g11450 and suspected interaction partners

  • Measure FRET signals in fixed tissues to detect close proximity between proteins

  • Include appropriate controls to account for spectral overlap and background fluorescence

Each approach has distinct advantages and limitations, making a multi-method strategy the most reliable for confirming genuine protein-protein interactions in plant systems.

How can At1g11450 antibodies be utilized in single-cell protein analysis of Arabidopsis tissues?

Emerging technologies for single-cell protein analysis using antibodies in plant systems include:

• Single-cell immunohistochemistry with high-resolution imaging:

  • Use At1g11450 antibodies with super-resolution microscopy techniques (STED, STORM, SIM)

  • Quantify protein abundance variations between different cell types within the same tissue

  • Combine with cell-type-specific markers to create protein expression maps at single-cell resolution

• Flow cytometry of protoplasts:

  • Isolate protoplasts from different tissues or cell-sorted populations

  • Fix and permeabilize cells for intracellular antibody labeling

  • Analyze protein expression heterogeneity across cell populations

• Mass cytometry adaptation for plant cells:

  • Develop metal-conjugated At1g11450 antibodies for CyTOF analysis

  • Combine with antibodies against other proteins for multi-parameter single-cell analysis

  • Create high-dimensional datasets to reveal cell subtypes based on protein expression patterns

• Microfluidic antibody-based protein analysis:

  • Capture individual plant cells in microfluidic chambers

  • Perform on-chip immunoassays with At1g11450 antibodies

  • Analyze protein expression in relation to single-cell transcriptomics data

These emerging approaches will enable researchers to move beyond bulk tissue analysis and understand cell-to-cell variation in At1g11450 protein expression, which is critical for understanding its function in complex developmental contexts.

What are the prospects for combining At1g11450 antibodies with CRISPR-engineered variants for functional studies?

Combining At1g11450 antibodies with CRISPR-engineered variants offers powerful opportunities for functional studies:

• Epitope accessibility studies:

  • Generate CRISPR-edited plants with small deletions or mutations in different protein domains

  • Use the antibody to test which modifications affect epitope recognition

  • Map functional domains by correlating antibody binding with protein function

• Structure-function analysis:

  • Create a series of CRISPR-edited plants with precise modifications to functional motifs

  • Use the antibody to quantify protein accumulation and localization for each variant

  • Correlate molecular changes with developmental or physiological phenotypes

• Conditional protein degradation systems:

  • Engineer CRISPR-mediated knock-in of degron tags into the At1g11450 locus

  • Use the antibody to monitor protein depletion kinetics after degron activation

  • Study immediate-early responses to protein loss without transcriptional adaptation

• Proximity-dependent protein modification:

  • Create CRISPR knock-in of enzyme fusion tags (APEX, TurboID) to At1g11450

  • Use the antibody to verify correct expression and localization of the fusion protein

  • Identify proteins and cellular structures in proximity to At1g11450 in different contexts

This integrated approach combines the specificity of antibody-based detection with the precision of CRISPR engineering to create a powerful platform for dissecting protein function in planta.

How can I access validated At1g11450 antibodies and related Arabidopsis research materials?

Researchers can access validated antibodies and related materials through these channels:

• Nottingham Arabidopsis Stock Centre (NASC):

  • The NASC maintains a collection of Arabidopsis antibodies developed through community initiatives

  • Many antibodies against key Arabidopsis root proteins are available through this resource

  • Visit their website to check availability of At1g11450 antibodies or related protein antibodies

• Arabidopsis Biological Resource Center (ABRC):

  • Provides seeds for knockout/knockdown lines and overexpression lines for At1g11450

  • These genetic resources are essential for antibody validation and functional studies

• Research collaborations:

  • Connect with authors who have published on At1g11450 or related proteins

  • Many researchers are willing to share antibodies and protocols through material transfer agreements

• Commercial sources:

  • Some commercial antibody providers now offer custom antibody development services for plant-specific proteins

  • Compare success rates and validation data when selecting commercial providers

When acquiring antibodies, request detailed validation data and protocols optimized for specific applications to maximize experimental success.

What standardized reporting should accompany publications using At1g11450 antibodies?

To promote reproducibility in research using At1g11450 antibodies, publications should include:

• Antibody specifications:

  • Source (commercial or laboratory-generated)

  • Clone number or identification code for monoclonal antibodies

  • Immunogen used for antibody production (peptide sequence or recombinant protein region)

  • Host species and antibody type (polyclonal, monoclonal, recombinant)

• Validation evidence:

  • Western blot images showing specificity in wild-type vs. knockout samples

  • Cross-reactivity testing with related proteins

  • Additional validation methods used (peptide competition, overexpression systems)

• Detailed methods:

  • Complete buffer compositions and pH values

  • Antibody dilutions and incubation conditions

  • Detection systems and exposure parameters

  • Image acquisition settings for microscopy applications

• Positive and negative controls:

  • Description of all controls used to validate experimental findings

  • Images or data from control experiments

• Quantification methods:

  • Software and algorithms used for image analysis or signal quantification

  • Statistical methods applied to the data